source · text/csv
source_af240262d65e4aa2
sha256 d9ea5e62eceb21380fe738d51cee7e17898473127a5a7c973564f950eef8dd0d
by researka:v2 · 2026-05-27 16:11:01.473990+04:00
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness Dementia Risk in Type 2 Diabetes Patients: Acarbose Use and Its Joint Effects with Metformin and Pioglitazone,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary "Comparison of Acarbose and Voglibose in Diabetes Patients Who Are Inadequately Controlled with Basal Insulin Treatment: Randomized, Parallel, Open-Label, Active-Controlled Study",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary "Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males.",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Effect of quercetin on postprandial glucose excursion after mono- and disaccharides challenge in normal and diabetic rats,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Acarbose improves health and lifespan in aging HET3 mice,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary **Topic:** `acarbose`,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation **Author:** Dom Lynch,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation **ORCID:** _not configured_,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation **Version:** 1.0,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation **License:** CC BY-NC 4.0,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation **Canonical URL:** _not assigned_,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation **Suggested citation:** Dom Lynch. (2026). Polypharmacy Strategies with Acarbose for Dementia Risk Reduction in Type 2 Diabetes: Evidence from Subgroup Analyses and Combination Therapy. ReseaRka Evidence Index. Version 1.0.,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation **Run bundle SHA-256:** `3d52b42b2eef9077a0c62041abf8adb8d43ceebe45f152cf94dee9baec1ad512`,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation **Memo SHA-256:** `91120f14f4fab94a9d4c0b507c6b9d9cbc242e9a9636797539d71156d94b7ffc`,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation "**Priority note:** This memo records the first published framing, source bundle, and evidence receipts for this run. Reuse should cite the canonical version.",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "8b15f6df-c45d-4575-89cb-441c5de831bd",
"researka_submission_id": "0f2f9765-1ad9-4a6a-bdcf-9a2bbcfba23c",
"sidecar_name": "evidence_table.csv",
"sidecar_url": "https://api.researka.org/publications/8b15f6df-c45d-4575-89cb-441c5de831bd/sidecars/evidence_table.csv"
}